Leaderboards/Renal Diseases and Glomerulopathies

Renal Diseases and Glomerulopathies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Felicitas E. Hengel
Universität Hamburg
2
C. Donado
Brigham and Women's Hospital
3
Valentina Raglianti
European Society for Sexual Medicine
4
Shiwan Hu
Beijing University of Chinese Medicine
5
David L. Hölscher
RWTH Aachen University
6
Jincan Zan
Peking University
7
Marija Holcar
University of Ljubljana
8
Marie V. Daugan
Idera Pharmaceuticals (United States)
9
Karen Lahme
Universität Hamburg
10
Nathalie Niyonzima
Norwegian University of Science and Technology

Papers

1
Autoantibodies Targeting Nephrin in Podocytopathies
New England Journal of Medicine|2024
245 cit.
2
Granzyme K activates the entire complement cascade
Nature|2025
109 cit.
3
Publication in Cell Communication and Signaling (2024) [108 citations, W4391945553]
Cell Communication and Signaling|2024
108 cit.
4
Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressants
Kidney International|2024
61 cit.
5
Publication in Kidney International Reports (2024) [56 citations, W4390700893]
Kidney International Reports|2024
56 cit.
6
Anti-slit Antibodies against Podocin and Kirrel1 in Pediatric and Adult Podocytopathies
Journal of the American Society of Nephrology|2025
37 cit.
7
Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy
Kidney International|2025
30 cit.
8
Passive transfer of patient-derived anti-nephrin autoantibodies causes a podocytopathy with minimal change lesions
Journal of Clinical Investigation|2025
26 cit.
9
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications
Nephrology Dialysis Transplantation|2025
7 cit.
10
tRigon: an R package and Shiny App for integrative (path-)omics data analysis
BMC Bioinformatics|2024
4 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Allen R. Hendricks
The University of Texas Southwestern Medical Center
2
Nicola M. Tomas
Universität Hamburg
3
Ladan Zand
Hypertension Institute
4
Alexandra Brenzel
Essen University Hospital
5
Anja Hasenberg
Essen University Hospital
6
Zuo‐Lin Li
Zhongda Hospital Southeast University
7
Ying Wang
Shanghai Jiao Tong University
8
Kshama Mehta
Massachusetts General Hospital
9
Patrick H. Nachman
University of Minnesota
10
Suzanne Wilhelmus
Leiden University Medical Center

Papers

1
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy
JAMA|2022
331 cit.
2
The classical pathway triggers pathogenic complement activation in membranous nephropathy
Nature Communications|2023
97 cit.
3
An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells
Kidney International|2024
45 cit.
4
Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice
Kidney International|2022
35 cit.
5
Activation of HIF-1α C-terminal transactivation domain protects against hypoxia-induced kidney injury through hexokinase 2-mediated mitophagy
Cell Death and Disease|2023
26 cit.
6
Passive transfer of patient-derived anti-nephrin autoantibodies causes a podocytopathy with minimal change lesions
Journal of Clinical Investigation|2025
26 cit.
7
Introduction of a novel chimeric active immunization mouse model of PLA2R1-associated membranous nephropathy
Kidney International|2023
17 cit.
8
Monoclonal Gammopathy and Its Association with Progression to Kidney Failure and Mortality in Patients with CKD
Clinical Journal of the American Society of Nephrology|2023
15 cit.
9
Tubular TMEM16A promotes tubulointerstitial fibrosis by suppressing PGC-1α-mediated mitochondrial homeostasis in diabetic kidney disease
Cellular and Molecular Life Sciences|2023
14 cit.
10
Anti-CD20 should be the first-line treatment in high-risk membranous nephropathy
Clinical Kidney Journal|2023
13 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
2
Martin R. Pollak
Beth Israel Deaconess Medical Center
3
Steven A. Krilis
Brigham and Women's Hospital
4
Jürgen Floege
RWTH Aachen University
5
Peter Mündel
Massachusetts General Hospital
6
Friedhelm Hildebrandt
Boston Children's Hospital
7
Vivette D. D’Agati
Columbia University
8
Philip F. Halloran
University of Alberta
9
David J. Salant
Boston University
10
Karl Tryggvason
Singapore Eye Research Institute

Papers

1
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
Journal of Thrombosis and Haemostasis|2006
7.1k cit.
2
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Kidney International|2021
2.4k cit.
3
M-Type Phospholipase A <sub>2</sub> Receptor as Target Antigen in Idiopathic Membranous Nephropathy
New England Journal of Medicine|2009
2.3k cit.
4
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Science|2010
2k cit.
5
Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic Syndrome
Molecular Cell|1998
1.9k cit.
6
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
New England Journal of Medicine|2007
1.8k cit.
7
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
Proceedings of the National Academy of Sciences|1990
1.6k cit.
8
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
American Journal of Transplantation|2011
1.6k cit.
9
Obesity-related glomerulopathy: An emerging epidemic
Kidney International|2001
1.3k cit.
10
Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis
Nature Genetics|2000
1.2k cit.

Reagents for Renal Diseases and Glomerulopathies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling TechnologyEvidence 66

S100A9 (D3U8M) Rabbit Monoclonal Antibody

#73425$169,369
View Evidence →

⭐ Top Rated

Best all-around

Cell Signaling Technology

SHMT2 (E8O8J) Rabbit Monoclonal Antibody

Cited in 9 papers
#37004$168,369
View Evidence →
Agilent/Dako

IgM

Cited in 8 papers
#F0203
View Evidence →
Cell Signaling TechnologyEvidence 66

Phospho-Stat2 (Tyr690) (D3P2P) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ Red 780 Conjugate)

Cited in 7 papers
#10164$486
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

LPCAT1 (E4V4B) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 12 papers
#81677$865
View Evidence →
Agilent/Dako

Wilms Tumor Protein 1

Cited in 12 papers
#M3561
View Evidence →
Cell Signaling TechnologyEvidence 65

Phospho-GADS (Thr262) (E8L3B) Rabbit Monoclonal Antibody

Cited in 9 papers
#78972$194,437
View Evidence →